These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
427 related articles for article (PubMed ID: 30358775)
1. Alkyl chain-modified cyclometalated iridium complexes as tunable anticancer and imaging agents. Laha P; De U; Chandra F; Dehury N; Khullar S; Kim HS; Patra S Dalton Trans; 2018 Nov; 47(44):15873-15881. PubMed ID: 30358775 [TBL] [Abstract][Full Text] [Related]
2. Highly potent half-sandwich iridium and ruthenium complexes as lysosome-targeted imaging and anticancer agents. Li J; Tian Z; Xu Z; Zhang S; Feng Y; Zhang L; Liu Z Dalton Trans; 2018 Nov; 47(44):15772-15782. PubMed ID: 30357192 [TBL] [Abstract][Full Text] [Related]
3. Half-Sandwich Iridium(III) and Ruthenium(II) Complexes Containing P^P-Chelating Ligands: A New Class of Potent Anticancer Agents with Unusual Redox Features. Li J; Tian M; Tian Z; Zhang S; Yan C; Shao C; Liu Z Inorg Chem; 2018 Feb; 57(4):1705-1716. PubMed ID: 29400963 [TBL] [Abstract][Full Text] [Related]
4. Novel and Versatile Imine-N-Heterocyclic Carbene Half-Sandwich Iridium(III) Complexes as Lysosome-Targeted Anticancer Agents. Yang Y; Guo L; Tian Z; Gong Y; Zheng H; Zhang S; Xu Z; Ge X; Liu Z Inorg Chem; 2018 Sep; 57(17):11087-11098. PubMed ID: 30133276 [TBL] [Abstract][Full Text] [Related]
5. Anticancer and antibacterial activity in vitro evaluation of iridium(III) polypyridyl complexes. Yi QY; Zhang WY; He M; Du F; Wang XZ; Wang YJ; Gu YY; Bai L; Liu YJ J Biol Inorg Chem; 2019 Mar; 24(2):151-169. PubMed ID: 30564887 [TBL] [Abstract][Full Text] [Related]
6. Mitochondria-targeted phosphorescent cyclometalated iridium(III) complexes: synthesis, characterization, and anticancer properties. Li Y; Liu B; Xu CX; He L; Wan YC; Ji LN; Mao ZW J Biol Inorg Chem; 2020 Jun; 25(4):597-607. PubMed ID: 32232583 [TBL] [Abstract][Full Text] [Related]
7. New Variations on the Theme of Gold(III) C Carboni S; Zucca A; Stoccoro S; Maiore L; Arca M; Ortu F; Artner C; Keppler BK; Meier-Menches SM; Casini A; Cinellu MA Inorg Chem; 2018 Dec; 57(23):14852-14865. PubMed ID: 30457328 [TBL] [Abstract][Full Text] [Related]
8. Synthesis, characterization and anticancer activity in vitro and in vivo evaluation of an iridium (III) polypyridyl complex. Yi QY; Wan D; Tang B; Wang YJ; Zhang WY; Du F; He M; Liu YJ Eur J Med Chem; 2018 Feb; 145():338-349. PubMed ID: 29331805 [TBL] [Abstract][Full Text] [Related]
9. Anticancer effect evaluation in vitro and in vivo of iridium(III) polypyridyl complexes targeting DNA and mitochondria. Zhang H; Tian L; Xiao R; Zhou Y; Zhang Y; Hao J; Liu Y; Wang J Bioorg Chem; 2021 Oct; 115():105290. PubMed ID: 34426145 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of anticancer effect in vitro and in vivo of iridium(III) complexes on gastric carcinoma SGC-7901 cells. Zhang WY; Wang YJ; Du F; He M; Gu YY; Bai L; Yang LL; Liu YJ Eur J Med Chem; 2019 Sep; 178():401-416. PubMed ID: 31202128 [TBL] [Abstract][Full Text] [Related]
11. Rhodamine-modified fluorescent half-sandwich iridium and ruthenium complexes: potential application as bioimaging and anticancer agents. Ma W; Guo L; Tian Z; Zhang S; He X; Li J; Yang Y; Liu Z Dalton Trans; 2019 Apr; 48(15):4788-4793. PubMed ID: 30892340 [TBL] [Abstract][Full Text] [Related]
12. Studies of anticancer activity in vitro and in vivo of iridium(III) polypyridyl complexes-loaded liposomes as drug delivery system. Zhang WY; Du F; He M; Bai L; Gu YY; Yang LL; Liu YJ Eur J Med Chem; 2019 Sep; 178():390-400. PubMed ID: 31202127 [TBL] [Abstract][Full Text] [Related]
13. An iridium (III) complex as potent anticancer agent induces apoptosis and autophagy in B16 cells through inhibition of the AKT/mTOR pathway. Tang B; Wan D; Wang YJ; Yi QY; Guo BH; Liu YJ Eur J Med Chem; 2018 Feb; 145():302-314. PubMed ID: 29331753 [TBL] [Abstract][Full Text] [Related]
14. Activation of the Ir-N(pyridine) Bond in Half-Sandwich Tethered Iridium(III) Complexes. Carrasco AC; Rodríguez-Fanjul V; Pizarro AM Inorg Chem; 2020 Nov; 59(22):16454-16466. PubMed ID: 33103884 [TBL] [Abstract][Full Text] [Related]
15. The Fluorine Effect in Zwitterionic Half-Sandwich Iridium(III) Anticancer Complexes. Yang Y; Guo L; Ge X; Zhu T; Chen W; Zhou H; Zhao L; Liu Z Inorg Chem; 2020 Jan; 59(1):748-758. PubMed ID: 31808678 [TBL] [Abstract][Full Text] [Related]
16. Anticancer potential of (pentamethylcyclopentadienyl)chloridoiridium(III) complexes bearing κP and κP,κS-coordinated Ph2 PCH2 CH2 CH2 S(O)x Ph (x=0-2) ligands. Ludwig G; Ranđelović I; Maksimović-Ivanić D; Mijatović S; Bulatović MZ; Miljković D; Korb M; Lang H; Steinborn D; Kaluđerović GN ChemMedChem; 2014 Jul; 9(7):1586-93. PubMed ID: 24470190 [TBL] [Abstract][Full Text] [Related]
17. Synthesis, Characterization, and Biological Properties of Steroidal Ruthenium(II) and Iridium(III) Complexes Based on the Androst-16-en-3-ol Framework. Koch V; Meschkov A; Feuerstein W; Pfeifer J; Fuhr O; Nieger M; Schepers U; Bräse S Inorg Chem; 2019 Dec; 58(23):15917-15926. PubMed ID: 31714764 [TBL] [Abstract][Full Text] [Related]